Bis-(4-methoxy-n-butyl)-ether | 17913-19-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Bis-(4-methoxy-n-butyl)-ether
• 英文别名: bis-(4-methoxy-butyl)-ether；Bis-(4-methoxy-butyl)-aether；4.4'-Dimethoxy-dibutylaether；1-Methoxy-4-(4-methoxybutoxy)butane
• CAS: 17913-19-8
• 化学式: C₁₀H₂₂O₃
• 分子量: 190.283
• InChiKey: SRFIRLBHIAWIGZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  13
• 可旋转键数：
  10
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  双(4-氯丁基)醚 、 sodium methylate 生成 Bis-(4-methoxy-n-butyl)-ether
  参考文献：
  名称：

  Alexander; Schniepp, Journal of the American Chemical Society, 1948, vol. 70, p. 1842

  摘要：

  DOI：

文献信息

• CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME
  申请人：Arvinas, Inc.

  公开号：US20180215731A1

  公开（公告）日：2018-08-02

  The description relates to cereblon E3 ligase binding compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present disclosure. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.

  该描述涉及cereblon E3连接酶结合化合物，包括包含相同成分的双功能化合物，这些化合物作为靶向泛素化的调节剂具有实用价值，尤其是抑制剂，可降解和/或以其他方式抑制根据本公开的双功能化合物。特别是，该描述提供了化合物，其一端含有与cereblon E3泛素连接酶结合的配体，另一端含有与目标蛋白结合的部分，使目标蛋白位于泛素连接酶附近以降解（和抑制）该蛋白。可以合成表现出广泛药理活性的化合物，与几乎所有类型的靶向多肽的降解/抑制一致。
• Method for producing n-alkenyl amides
  申请人：——

  公开号：US20030028035A1

  公开（公告）日：2003-02-06

  A process for preparing N-alkenyl-amides by reacting the corresponding NH-amides with acetylenes in the liquid phase in the presence of basic alkali metal compounds and of a cocatalyst comprises using as the cocatalyst compounds of the general formulae (Ia) and/or (Ib) R 1 O—(CH 2 CH 2 CH 2 CH 2 O) n —H  (Ia): R 1 O—(CH 2 CH 2 CH 2 CH 2 O) n —R 2 ,  (Ib): where n is 1, 2 or 3 and R 1 and R 2 are independently C 1 - to C 6 -alkyl or C 2 - to C 6 -alkenyl, or together a butenyl unit.

  制备N-烯基酰胺的过程包括通过在液相中让相应的NH-酰胺与炔烃反应，在碱性金属化合物和共催化剂的存在下，作为共催化剂使用的是具有以下通式(Ia)和/或(Ib)的化合物：R1O—(CH2CH2CH2CH2O)n—H  (Ia):R1O—(CH2CH2CH2CH2O)n—R2,  (Ib):其中n为1、2或3，R1和R2独立地为C1至C6烷基或C2至C6烯基，或者共同构成一个丁烯基团。
• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES
  申请人：Arvinas, Inc.

  公开号：US20180179183A1

  公开（公告）日：2018-06-28

  The present disclosure relates to bifunctional compounds, which find utility as modulators of Rapidly Accelerated Fibrosarcoma (RAF, such as c-RAF, A-RAF and/or B-RAF; the target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand which binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein RAF, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein, or the constitutive activation of the target protein, are treated or prevented with compounds and compositions of the present disclosure.

  本公开涉及双功能化合物，其作为快速加速纤维肉瘤（RAF，如c-RAF、A-RAF和/或B-RAF；目标蛋白）的调节剂而发挥作用。具体而言，本公开涉及含有一端为Von Hippel-Lindau、cereblon、凋亡抑制蛋白或鼠双分子同源物2配体的双功能化合物，该配体与相应的E3泛素连接酶结合，并且另一端含有结合目标蛋白RAF的基团，使得目标蛋白与泛素连接酶靠近，以实现目标蛋白的降解（和抑制）。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性范围。本公开的化合物和组合物用于治疗或预防由目标蛋白的聚集或积累，或目标蛋白的构成性激活导致的疾病或紊乱。
• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ENHANCER OF ZESTE HOMOLOG 2 POLYPEPTIDE
  申请人：Arvinas, Inc.

  公开号：US20180177750A1

  公开（公告）日：2018-06-28

  The present disclosure relates to bifunctional compounds, which find utility as modulators of enhancer of zeste homolog 2 (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand which binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本公开涉及双功能化合物，其作为增强子锁定同源2的调节剂而发挥作用。具体而言，本公开涉及包含一端为Von Hippel-Lindau、cereblon、凋亡抑制蛋白或鼠双分子同源2配体的双功能化合物，该配体与相应的E3泛素连接酶结合，另一端含有结合目标蛋白的基团，使目标蛋白靠近泛素连接酶以实现目标蛋白的降解（和抑制）。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性范围。本公开的化合物和组合物用于治疗或预防由目标蛋白聚集或积累导致的疾病或紊乱。
• Method for producing alkenyl ethers
  申请人：——

  公开号：US20030114715A1

  公开（公告）日：2003-06-19

  Alkenyl ethers are prepared by reacting the corresponding alcohols or phenols with acetylenes in the liquid phase in the presence of basic alkali metal compounds and a cocatalyst comprising compounds of the formula (Ia) and/or (Ib) R 1 O—(CH 2 CH 2 CH 2 CH 2 O) n— H  (Ia) R 1 O—(CH 2 CH 2 CH 2 CH 2 O) n— H 2 ,  (Ia) where R 1 , R 2 are, independently of one another, C 1 -C 6 -alkyl or C 2 -C 6 -alkenyl, or R 1 and R 2 together form a butyl unit and n is 1, 2, 3, 4 or 5.

  烯丙醚通过在液相中存在碱性金属化合物和协同催化剂的情况下，将相应的醇或酚与乙炔反应制备而成，其中所述协同催化剂包括化合物(Ia)和/或(Ib)的公式，(Ia)R1O—(CH2CH2CH2CH2O)n—H  (Ia)R1O—(CH2CH2CH2CH2O)n—H2,  (Ia)其中，R1，R2是独立的C1-C6烷基或C2-C6烯基，或R1和R2共同形成丁基单元，n为1、2、3、4或5。